The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

to related objects

Alternative title: Die Regulierung der PD-L1-Sekretion in Extrazellulären Vesikeln durch Melanomzellen

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2023

Keyword: Krebs

Event: Veröffentlichung

(where): Erlangen

(who): Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

(when): 2023

Creator: Liu, Jie

Contributor: Baur, Andreas
Baur, Andreas
Taubert, Helge

DOI: 10.25593/open-fau-15

URN: urn:nbn:de:101:1-2023122107160650205210

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Liu, Jie
Baur, Andreas
Baur, Andreas
Taubert, Helge
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

Time of origin

2023

Other Objects (12)

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects

MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages

Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma

Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects

Related objects

Reset password